A 12-Week Open-Label Non-Interventional Evaluation of Atacand® (Candesartan) Efficacy, Tolerability, Compliance and Treatment Satisfaction in Patients With Arterial Hypertension

AstraZeneca0 个研究点目标入组 750 人开始时间: 2006年3月最近更新: 2009年2月6日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: AstraZeneca
入组人数: 750
主要终点: Systolic and diastolic blood pressure reduction

研究概览研究设计入排标准结局指标研究者记录与标识符相似试验

研究概览

简要总结

This open label, non-interventional study is to show the efficacy of antihypertensive treatment with Atacand in hypertensive patients. Efficacy is to be evaluated based on the difference in systolic and diastolic blood pressure at baseline and at both follow-up visits.

研究设计

研究类型: Observational
时间视角: Prospective

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•a patient with arterial hypertension who has been prescribed Atacand according to physician's judgement, irrespective of the inclusion in the study

排除标准

•hypersensitivity to candesartan or any other ingredient of Atacand
•liver function impairment and/or cholestasis
•severe renal insufficiency
•woman of child-bearing potential and not using appropriate contraceptive measures, pregnancy or lactation

结局指标

主要结局

Systolic and diastolic blood pressure reduction

时间窗: 12 weeks

次要结局

Incidence and reasons of treatment discontinuation(12 weeks)
Patient treatment satisfaction (using 5-point answering scale) as the measure of the patient's overall tolerance(12 weeks)
Physician overall evaluation of the therapy (using 5-point answering scale)(12 weeks)

研究者

发起方

AstraZeneca

申办方类型

Industry

相似试验

进行中（未招募）

不适用

Open-Label, 12-Month Safety and Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Disease Subjects

EUCTR2006-000578-53-DEAbbott Laboratories70

招募中

3 期

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

NCT03955445Novartis Pharmaceuticals225

进行中（未招募）

1 期

To evaluate the long-term efficacy and tolerability of treatment with dimethyl fumarate in adults with chronic plaque psoriasis.chronic plaque psoriasisMedDRA version: 20.0Level: LLTClassification code 10071117Term: Plaque psoriasisSystem Organ Class: 100000004858

EUCTR2017-003818-11-ITALMIRALL SPA300

进行中（未招募）

不适用

An Open-Label, Long-Term Treatment Study to assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus

EUCTR2008-001432-13-CZMerz Pharmaceuticals GmbH840

进行中（未招募）

不适用

An Open-Label, Long-Term Treatment Study to assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitusong-term safety, tolerability and efficacy of Neramexane in Patients with subjective Tinnitus.MedDRA version: 9.1Level: LLTClassification code 10042398Term: Subjective tinnitus

EUCTR2008-001432-13-NLMerz Pharmaceuticals GmbH840